Background: This prospective multicenter registry used intravascular ultrasound (IVUS) in patients with definite stent thrombosis (ST) to compare rates of incomplete stent apposition (ISA), stent fracture and stent expansion in patients treated with drug-eluting (DES) versus bare metal (BMS) stents. ST is a rare, but potential life threatening event after coronary stent implantation. The etiology seems to be multifactorial. Methods: 124 patients with definite ST were assessed by IVUS during the acute ST event. The study was conducted in 15 high-volume percutaneous coronary intervention -centers in the Nordic-Baltic countries. Results: In early or late ST there were no differences in ISA between DES and BMS. In very late ST, ISA was a more f...
To assess the fate of incomplete stent apposition (ISA) after deployment of sirolimus-eluting stents...
The objective of this study was to examine long-term changes after bare metal stent implantation in ...
ObjectivesAcute and late stent malapposition (SM) after bare-metal stents (BMS) and sirolimus-elutin...
BACKGROUND: This prospective multicenter registry used intravascular ultrasound (IVUS) in patients w...
ObjectivesThis study compared intravascular ultrasound (IVUS) findings at drug-eluting stent (DES) a...
Introduction: Drug-eluting stents (DES) reduce the risk of restenosis after percutaneous coronary in...
Drug-eluting stent (DES) thrombosis (ST) can be devastating. The study aim was to evaluate intravasc...
BACKGROUND: Stent thrombosis may occur late after drug-eluting stent (DES) implantation, and its cau...
Background: The impact of incomplete stent apposition (ISA) after drug-eluting stent implantation de...
BACKGROUND: Intravascular ultrasound of drug-eluting stent (DES) thrombosis (ST) reveals a high inci...
ObjectivesThis study compared intravascular ultrasound (IVUS) findings at drug-eluting stent (DES) a...
ObjectivesWe sought to determine the 2-year impact of early and late-acquired incomplete stent appos...
ObjectivesWe sought to identify the frequency of incomplete stent apposition (ISA) in sirolimus-elut...
BACKGROUND: Prior small to modest-sized studies suggest a benefit of intravascular ultrasound (IVUS)...
textabstractBACKGROUND: The clinical impact of late incomplete stent apposition (ISA) for drug-eluti...
To assess the fate of incomplete stent apposition (ISA) after deployment of sirolimus-eluting stents...
The objective of this study was to examine long-term changes after bare metal stent implantation in ...
ObjectivesAcute and late stent malapposition (SM) after bare-metal stents (BMS) and sirolimus-elutin...
BACKGROUND: This prospective multicenter registry used intravascular ultrasound (IVUS) in patients w...
ObjectivesThis study compared intravascular ultrasound (IVUS) findings at drug-eluting stent (DES) a...
Introduction: Drug-eluting stents (DES) reduce the risk of restenosis after percutaneous coronary in...
Drug-eluting stent (DES) thrombosis (ST) can be devastating. The study aim was to evaluate intravasc...
BACKGROUND: Stent thrombosis may occur late after drug-eluting stent (DES) implantation, and its cau...
Background: The impact of incomplete stent apposition (ISA) after drug-eluting stent implantation de...
BACKGROUND: Intravascular ultrasound of drug-eluting stent (DES) thrombosis (ST) reveals a high inci...
ObjectivesThis study compared intravascular ultrasound (IVUS) findings at drug-eluting stent (DES) a...
ObjectivesWe sought to determine the 2-year impact of early and late-acquired incomplete stent appos...
ObjectivesWe sought to identify the frequency of incomplete stent apposition (ISA) in sirolimus-elut...
BACKGROUND: Prior small to modest-sized studies suggest a benefit of intravascular ultrasound (IVUS)...
textabstractBACKGROUND: The clinical impact of late incomplete stent apposition (ISA) for drug-eluti...
To assess the fate of incomplete stent apposition (ISA) after deployment of sirolimus-eluting stents...
The objective of this study was to examine long-term changes after bare metal stent implantation in ...
ObjectivesAcute and late stent malapposition (SM) after bare-metal stents (BMS) and sirolimus-elutin...